It has been suggested that, at the onset of AD, intra-neuronal accumulation of β-amyloid causes a slight decrease in CX3CL1/CX3CR1 signaling, resulting in increased Aβ phagocytosis and hyperphosphorylation of tau [39]. Here, MAPT is linked to Alzheimer disease.